NeurosciencebioRxivPreprint
Peptide-based inhibitors of Tau aggregation as a potential therapeutic for Alzheimer's disease and other Tauopathies
Anthony Aggidis, Shreyasi Chatterjee, David J. Townsend…·David Allsop
This paper develops a peptide inhibitor, RI-AG03, that reduces Tau aggregation in vitro and improves Tauopathy symptoms in Drosophila.
7 citations